Koninklijke Philips NVRYLPF +2.21%72 EV-to-EBITDA is 10.62 as of Jul. 06, 2026, which is 43% below its 10-year median of 18.68. GuruFocus rates RYLPF with a GF Score™ of 72/100 and a GF Value™ of $25.39 (Fairly Valued). The stock has 5 warning signs investors should review. Among 512 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 63.28% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Koninklijke Philips NV's enterprise value is $33,108 Mil.
Koninklijke Philips NV's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $3,116 Mil. Therefore, Koninklijke Philips NV's EV-to-EBITDA for today is 10.62.
The historical rank and industry rank for Koninklijke Philips NV's EV-to-EBITDA or its related term are showing as below:
RYLPF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -208.44 Med: 18.68 Max: 62.34
Current: 11.03
During the past 13 years, the highest EV-to-EBITDA of Koninklijke Philips NV was 62.34. The lowest was -208.44. And the median was 18.68.
RYLPF's EV-to-EBITDA is ranked better than 63.28% of 512
companies
in the Medical Devices & Instruments industry
Industry Median: 14.495
vs RYLPF: 11.03
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Koninklijke Philips NV's PE Ratio (TTM) for today is calculated as:
Koninklijke Philips NV's share price for today is $28.012.
Koninklijke Philips NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.188.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Koninklijke Philips NV's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's EV-to-EBITDA falls into.
Koninklijke Philips NV's current Enterprise Value is $33,108 Mil.
Koninklijke Philips NV's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,116 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koninklijke Philips NV (RYLPF) has a EV-to-EBITDA of 10.62 as of Jul. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Koninklijke Philips NV. This is 43% below median its historical median of 18.68. According to the industry distribution chart, Koninklijke Philips NV ranks #188 out of 512 companies in the Medical Devices & Instruments industry, placing it in the top 36.7%.
Is Koninklijke Philips NV's EV-to-EBITDA too high?
Koninklijke Philips NV's current EV-to-EBITDA of 10.62 is 43% below median its 10-year median of 18.68. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.50. Koninklijke Philips NV's value of 10.62 is 26.7% below this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #188 out of 512 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #188 out of 512 companies for EV-to-EBITDA. This puts Koninklijke Philips NV in the upper half of its industry. The industry median EV-to-EBITDA is 14.50. Koninklijke Philips NV's value of 10.62 is 26.7% below this benchmark. While the company's 10-year median is 18.68 vs. the industry median of 14.50, Koninklijke Philips NV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.50, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current EV-to-EBITDA of 10.62 is 26.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Koninklijke Philips NV. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current EV-to-EBITDA is 10.62, which is 43% below median its own 10-year median of 18.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.39, compared to a current price of $28.01 — trading 10.3% above its estimated fair value. The current EV-to-EBITDA is 10.62, which is 43% below median its 10-year median of 18.68 and 26.7% below the Medical Devices & Instruments industry median of 14.50. Koninklijke Philips NV's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current EV-to-EBITDA is 10.62 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of $28.01 is trading 10.3% above its estimated GF Value™ of $25.39.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
EV-to-EBITDA: 10.62 (43% below median its 10-year median of 18.68)
GF Value™: $25.39 vs. price of $28.01 (10.3% above fair value)
Industry Position: 26.7% below the Medical Devices & Instruments median (#188 of 512)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
72GF Score
Get the complete analysis for RYLPF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 
